v3.26.1
Financial Instruments (Tables)
 6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Consolidated Statement of Cash Flows
The following table reconciles cash, cash equivalents, and restricted cash reported on the condensed consolidated balance sheets to the corresponding total amounts presented in the condensed consolidated statements of cash flows.
June 30,
20262025
Cash and cash equivalents$256,692 $159,309 
Restricted cash (included in prepaid and other assets)656 - 
Restricted cash (included in other long-term assets)332 105 
Total cash, cash equivalents and restricted cash257,680 159,414 
Schedule of Amortized Cost, Unrealized Gains and Losses and the Fair Value The following table summarizes the amortized cost, unrealized gains and losses and the fair value at June 30, 2026 and December 31, 2025.
Amortized
Cost		Gross
Unrealized
Losses		Gross
Unrealized
Gains		Fair Value
June 30, 2026:
Money Market Funds included in Cash Equivalents$8,649 $- $- $8,649 
December 31, 2025:
Money Market Funds included in Cash Equivalents$4,805 $- $- $4,805 
Commercial Paper3,694 - - 3,694 
Total December 31, 2025 short-term assets$8,499 $- $- $8,499 
Schedule of Carrying Value and Fair Value of Financial Assets and Liabilities
The following table provides the carrying value and fair value of the Company’s financial assets and liabilities measured at fair value on a reoccurring basis as of June 30, 2026 and December 31, 2025:
Carrying
Value		Level 1Level 2Level 3
June 30, 2026:
Money Market Funds and Cash Equivalents$8,649 $8,649 $- $- 
Marketable Equity Securities9,364 9,364 - - 
Contingent Consideration liability111,619 - - 111,619 
December 31, 2025:
Money Market Funds and Cash Equivalents$4,805 $4,805 $- $- 
Commercial Paper3,694 - 3,694 - 
Total December 31, 2025 short-term assets$8,499 $4,805 $3,694 $- 
Marketable Equity Securities10,364 10,364 - - 
Contingent Consideration liability102,116 - - 102,116